On September 18th, the Food and Drug Administration reprimanded JUUL for their false marketing around e-cigarettes being a safer alternative to cigarettes. The FDA ordered…
Featured Story
Smith & Johnson proudly supports
More Featured Stories
Health
2 min read
What Parents Should Know About Vaping
In a recent article from Stanford University School of Medicine, Dr. Bonnie Halpern-Felsher discussed her research on young people’s perceptions of vaping products. Dr. Halpern-Felsher…
Health
3 min read
Is Vaping Causing Seizures?
In April, the FDA announced that it was investigating 32 reports of people suffering seizures after vaping. Since then, 92 more reports were made to…
Health
3 min read
How JUUL Hooked Teenagers
“JUUL’s breakthrough “nicotine salts” formula for vaping liquid, now the industry standard, set off an epidemic of e-cigarette use by U.S. Teenagers. Now Investigators want…
Recently Added
JUUL and Vaping: Rising Use & Rising Deaths
There are two very concerning trends in vaping — rising use among teens and rising injury and death according to the Center for Disease Control…
Detroit Hospital Performs First of It’s Kind Vaping-related Lung Transplant
Doctors at the Henry Ford Hospital in Detroit “have performed a double lung transplant on a man whose lungs were damaged from vaping.” From USA…
Teen Vaping and JUUL’s Market Share Continue to Increase
In just three short years, the number of teens who reported vaping nicotine in the past month has more than doubled. The Journal of the…
Of Interest
California Man Diagnosed with Colon Cancer After Taking Zantac for 8 Years
A California man recently filed a new Zantac lawsuit in the U.S. District Court for the Southern District of California. He claims that after taking…
Zantac Recall: Cancer Link Probable – Updates and Investigation
Zantac, a common anti-heartburn medication whose generic version is ranitidine, has come under scrutiny for containing a probable human carcinogen (a cancer-causing agent). Testing has…
Lawmakers Seek More Action on Ranitidine, While JAMA Withholds New Study
In September 2019, the U.S. Food and Drug Administration (FDA) warned healthcare providers and patients that ranitidine drugs, including brand-name Zantac, had been found to…
